Outline

Date and time :

Day1:Thursday, 4th March 2021, 10:00-12:00 (Tokyo)
Day2:Friday, 5th March 2021, 10:00 12:00 (Tokyo)

Other cities

Date and time :

Day1 Wednesday, 3rd March 2021, 20:00-22:00 ー Bethesda, Washington, D.C.
Day2 Thursday, 4th March 2021, 20:00-22:00 ー Bethesda, Washington, D.C.

Day1 Thursday, 4th March 2021, 7:30-19:30 ー Naypyidaw
Day2 Friday, 5th March 2021, 7:30-19:30 ー Naypyidaw

Day1 Thursday, 4th March 2021, 8:00-10:00 ー Bangkok
Day2 Friday, 5th March 2021, 8:00-10:00 ー Bangkok

Day1 Thursday, 4th March 2021, 8:00-10:00 ー Phnom Penh
Day2 Friday, 5th March 2021, 8:00-10:00 ー Phnom Penh

Day1 Thursday, 4th March 2021, 8:00-10:00 ー Jakarta
Day2 Friday, 5th March 2021, 8:00-10:00 ー Jakarta

Day1 Thursday, 4th March 2021, 8:00-10:00 ー Hanoi
Day2 Friday, 5th March 2021, 8:00-10:00 ー Hanoi

Day1 Thursday, 4th March 2021, 9:00-11:00 ー Beijing
Day2 Friday, 5th March 2021, 9:00-11:00 ー Beijing

Day1 Thursday, 4th March 2021, 9:00-11:00 ー Manila
Day2 Friday, 5th March 2021, 9:00-11:00 ー Manila

Day1 Thursday, 4th March 2021, 9:00-11:00 ー Kuala Lumpur
Day2 Friday, 5th March 2021, 9:00-11:00 ー Kuala Lumpur

Day1 Thursday, 4th March 2021, 9:00-11:00 ー Singapore
Day2 Friday, 5th March 2021, 9:00-11:00 ー Singapore

Day1 Thursday, 4th March 2021, 12:00-14:00 ー Sydney, Canberra
Day2 Friday, 5th March 2021, 12:00-14:00 ー Sydney, Canberra

Day1 Thursday, 4th March 2021, 14:00-16:00 ー Dunedin, Wellington
Day2 Friday, 5th March 2021, 14:00-16:00 ー Dunedin, Wellington

Event format : Online

This is an online event. Live stream of the event will be shown to all webinar participants. The live streaming page will be shared by e-mail after registration. You will be able to access the streaming page 30 minutes prior to the start of the event. 

Language : English

※ Please kindly note that we will close the registration after reaching 350 Attendees.

If you have difficulty accessing the link, please try using another device (smartphone, etc.)

Host Organization

The Japan Agency for Medical Research and Development (AMED)

Aim

Antimicrobial Resistance (AMR) is a global challenge that is particularly acute in the Asia-Pacific Region. This workshop aims to provide a scientific basis for the establishment of a trans-Pacific AMR coordinating mechanism as an element of the One Health approach. Public funding institutions from the East Asia Summit participating countries (now forming e-ASIA Member Organizations) and researchers have discussed potential value and possibility of forming a coordinating mechanism to facilitate information sharing on AMR programs, policies, and strategies across countries in the Asia-Pacific Region.
In the meantime, on the policy side, the Ministry of Health and Welfare (MoHW) in Japan and the Western Pacific Regional Office of WHO (WPRO) have held several AMR policy discussions within the context of the One Health Approach in order to initiate the development of a regional policy network. In April 2017, the Japan’s first action plan on AMR was established at the Ministerial Conference and the Tokyo AMR One-Health Conference has been held once every two years with many participants from several sectors such as high officials from the Food and Agriculture Organization (FAO) and the World Health Organization (WHO) of the United Nations and World Organization for Animal Health (OIE).
With these backgrounds, AMED has invited various experts in the field of AMR in this region, including participants of the Tokyo AMR One-Health Conference 2021, in order to promote seamless cooperation and discussion, considering scientific and policy perspectives.

GOALS OF THE WORKSHOP
1. To share information on current AMR research activities and to identify priorities for future AMR research in the Asia-Pacific Region, including priorities for the future e-ASIA Joint Research Program focused on AMR.

2. To facilitate scientific and policy discussions about steps regional governments can take to improve regional collaboration and to better understand and address AMR in the region – within the One Health approach.

Agenda at a glance

Day1

TIME (Japan Standard Time) PROGRAMME
10:00-10:10 OPENING REMARKS
10:10-10:40 KEYNOTE SPEECHES
10:40-11:25 SESSION I
11:25-12:00 PANEL DISCUSSION

Day2

TIME (Japan Standard Time) PROGRAMME
10:00-10:10 REVIEWING Day 1
10:10-10:45 SESSION II
10:45-11:25 SESSION III
11:25-11:50 PANEL DISCUSSION
11:50-12:00 CLOSING

Agenda

  • Day1
    March 4th
    (March 3rd for USA only)
  • Day2
    March 5th
    (March 4th for USA only)
TIME
PROGRAMME
OPENING REMARKS
TIME 20:00-20:10 (Bethesda, Washington, D.C.)
7:30-7:40 (Naypyidaw)
8:00-8:10 (Bangkok)
9:00-9:10 (Beijing, Manila, Singapore)
10:00-10:10 (Tokyo)
12:00-12:10 (Sydney,Canberra)
14:00-14:10 (Dunedin,Wellington)
PROGRAMME

Welcome Remarks

Yoshinao Mishima, President, AMED, Japan

Brief Overview of Objectives of AMR Workshop

Masahiko Noda,
Managing Director, Department of International Strategy, AMED, JAPAN

KEYNOTE SPEECHES
TIME 20:10-20:25 (Bethesda, Washington, D.C.)
7:40-7:55 (Naypyidaw)
8:10-8:25 (Bangkok)
9:10-9:25 (Beijing, Manila, Singapore)
10:10-10:25 (Tokyo)
12:10-12:25 (Sydney,Canberra)
14:10-14:25 (Dunedin,Wellington)
PROGRAMME

The “One Health” perspective on AMR

Peter Collignon, Professor, The Australian National University, AUSTRALIA

TIME 20:25-20:40 (Bethesda, Washington, D.C.)
7:55-8:10 (Naypyidaw)
8:25-8:40 (Bangkok)
9:25-9:40 (Beijing, Manila, Singapore)
10:25-10:40 (Tokyo)
12:25-12:40 (Sydney,Canberra)
14:25-14:40 (Dunedin,Wellington)
PROGRAMME

TATFAR and the Value of Networking (Trans Atlantic Task Force on Antimicrobial Resistance)

Dennis Dixon, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA

SESSION I

(TBD) AMR in One Health

Chair: Prasit Palittapongarnpim, Professor, NSTDA, THAILAND

TIME 20:40-20:55 (Bethesda, Washington, D.C.)
8:10-8:25 (Naypyidaw)
8:40-8:55 (Bangkok)
9:40-9:55 (Beijing, Manila, Singapore)
10:40-10:55 (Tokyo)
12:40-12:55 (Sydney,Canberra)
14:40-14:55 (Dunedin,Wellington)
PROGRAMME

Thailand AMR Program in Response to Global Action Plan on AMR

Visanu Thamlikitkul, Professor, Faculty of Medicine Siriraj Hospital at Mahidol University, THAILAND

TIME 20:55-21:10 (Bethesda, Washington, D.C.)
8:25-8:40 (Naypyidaw)
8:55-9:10 (Bangkok)
9:55-10:10 (Beijing, Manila, Singapore)
10:55-11:10 (Tokyo)
12:55-13:10 (Sydney,Canberra)
14:55‐15:10 (Dunedin,Wellington)
PROGRAMME

One Health approach for exploring the emergence and spread of mobile colistin resistance

Yang Wang,
Professor, China Agricultural University, CHINA

TIME 21:10-21:25 (Bethesda, Washington, D.C.)
8:40-8:55 (Naypyidaw)
9:10-9:25 (Bangkok)
10:10-10:25 (Beijing, Manila, Singapore)
11:10-11:25 (Tokyo)
13:10-13:25 (Sydney,Canberra)
15:10-15:25 (Dunedin,Wellington)
PROGRAMME

Overview of The Research Project on Livestock AMR in Japan

Sota Kobayashi,
Parasitology Unit Leader, National Agriculture and Food Research Organization (NARO), JAPAN

PANEL DISCUSSION
TIME 21:25-22:00 (Bethesda, Washington, D.C.)
8:55-9:30 (Naypyidaw)
9:25-10:00 (Bangkok)
10:25-11:00 (Beijing, Manila, Singapore)
11:25-12:00 (Tokyo)
13:25-14:00 (Sydney,Canberra)
15:25-16:00 (Dunedin,Wellington)
PROGRAMME

Strategies to Prevent or Reduce AMR in One Health

Coordinator:Haruo Watanabe,
Program supervisor/officer, AMED, JAPAN

Discussion Points (TBD):
1. Current Issues of AMR Impacting on Human Health
2. Global Collaboration towards the One Health Approach in AMR

Panelists at Day1

Peter Collignon Professor, The Australian National University, AUSTRALIA
Dennis Dixon, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA
Visanu Thamlikitkul, Professor, Faculty of Medicine Siriraj Hospital at Mahidol University, THAILAND
Yang Wang, Professor, China Agricultural University, CHINA
Prasit Palittapongarnpim, Professor, NSTDA, THAILAND
Sota Kobayashi, Parasitology Unit Leader, National Agriculture and Food Research Organization (NARO), JAPAN
Satoshi Mitarai, Professor/Head, The Research Institute of Tuberculosis, JAPAN
Li Yang Hsu, Saw Swee Hock School of Public Health, National University of Singapore, SINGAPORE

TIME
PROGRAMME
REVIEWING Day1
TIME 20:00-20:10 (Bethesda, Washington, D.C.)
7:30-7:40 (Naypyidaw)
8:00-8:10 (Bangkok)
9:00-9:10 (Beijing, Manila, Singapore)
10:00-10:10 (Tokyo)
12:00-12:10 (Sydney,Canberra)
14:00-14:10 (Dunedin,Wellington)
PROGRAMME

Coordinator: Haruo Watanabe,
Program supervisor/officer, AMED, JAPAN

Q&A on Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)

SESSION II

Global AMR and Regional AMR Coordination

Chair: Jane Knisely, NIAID, USA

TIME 20:10-20:30 (Bethesda, Washington, D.C.)
7:40-8:00 (Naypyidaw)
8:10-8:30 (Bangkok)
9:10-9:30 (Beijing, Manila, Singapore)
10:10-10:30 (Tokyo)
12:10-12:30 (Sydney,Canberra)
14:10-14:30 (Dunedin,Wellington)
PROGRAMME

Antimicrobial Resistance around the World Showcase presentations by e-ASIA MO

AMR Research in Myanmar: Current Situation, Challenges and Ways Forward

Wah Wah Aung, Director (Research), Advanced Molecular Research Centre, Department of Medical Research, Ministry of Health and Sports, MYANMAR

ANTIMICROBIAL RESISTANCE (AMR) IN THE PHILIPPINES

Jaime C. Montoya, Executive Director, Professor, Philippine Council for Health Research and Development (PCHRD)/ Department of Science and Technology, University of the Philippines College of Medicine (UPCM), PHILIPPINES

TIME 20:30-20:45 (Bethesda, Washington, D.C.)
8:00-8:15 (Naypyidaw)
8:30-8:45(Bangkok)
9:30-9:45 (Beijing, Manila, Singapore)
10:30-10:45 (Tokyo)
12:30-12:45 (Sydney,Canberra)
14:30-14:45 (Dunedin,Wellington)
PROGRAMME

U.S. Engagement in International AMR Activities

Lynn Filpi,
The U.S. Department of Health and Human Services / Office of the Secretary/ Office of Global Affairs (HHS/OS/OGA), USA

SESSION III

Strategies for Improving Antimicrobial Drug Development

Chair: Tania Sorrell, The University of Sydney, AUSTRALIA

TIME 20:45-21:25 (Bethesda, Washington, D.C.)
8:15-8:55 (Naypyidaw)
8:45-9:25 (Bangkok)
9:45-10:25 (Beijing, Manila, Singapore)
10:45-11:25 (Tokyo)
12:45-13:25 (Sydney,Canberra)
14:45-15:25 (Dunedin,Wellington)
PROGRAMME

Strategy for improving the development of treatments for priority drug-resistant infections

Seamus O’Brien, Director of Research & Development, Global Antibiotic Research & Development Partnership (GARDP), SWITZERLAND

Strategies for improving antimicrobial drug development for the treatment of Mycobacterium tuberculosis

Matthew McNeil, Research Fellow, Department of Microbiology and Immunology, University of Otago, NEW ZEALAND

Antimicrobial Drug Development in Japan

Keiji Hirai, Senior Advisor, Kyorin Pharmaceutical Co., Ltd, JAPAN

Alternatives to Improving Antimicrobial Drug Development

Ruth Zadoks, Professor, Sydney School of Veterinary Science, The University of Sydney, AUSTRALIA

PANEL DISCUSSION
TIME 21:25-21:50 (Bethesda, Washington, D.C.)
8:55-9:20 (Naypyidaw)
9:25-9:50 (Bangkok)
10:25-10:50 (Beijing, Manila, Singapore)
11:25-11:50 (Tokyo)
13:25-13:50 (Sydney,Canberra)
15:25-15:50 (Dunedin,Wellington)
PROGRAMME

Strategies to Prevent or Reduce AMR in One Health

Coordinator: Haruo Watanabe
Program supervisor/officer, AMED, JAPAN

Discussion Points (Continued from Discussion Points on Day 1):

3. Key Strategies for Solving AMR Problems
-What kind of challenges that we are facing on funding?
(At country & regional levels)
- What is the role of industries in forming a cooperative research network toward the development?
- What kind of supporting system can be developed for the developing countries?

4. Future Directions for AMR Research and Coordination with Relevant Activities
- What kind of research network should be built and how can we do that? Who will take the leadership?

CLOSING
TIME 21:50-22:00 (Bethesda, Washington, D.C.)
9:20-9:30 (Naypyidaw)
9:50-10:00 (Bangkok)
10:50-11:00 (Beijing, Manila, Singapore)
11:50-12:00 (Tokyo)
13:50-14:00 (Sydney,Canberra)
15:50-16:00 (Dunedin,Wellington)
PROGRAMME

Brief Summary of Discussions and Next Steps

Panelists at Day2

・Lynn Filpi, The U.S. Department of Health and Human Services / Office of the Secretary/ Office of Global Affairs (HHS/OS/OGA), USA
・Tatsuro Kuzuki, Scientific Liaison, DNDi Japan, JAPAN
・Ruth Zadoks, Professor, Sydney School of Veterinary Science, The University of Sydney, AUSTRALIA
・Matthew McNeil, Research Fellow, Department of Microbiology and Immunology, University of Otago, NEW ZEALAND
・Keiji Hirai, Senior Advisor, Kyorin Pharmaceutical Co., Ltd, JAPAN
・Tania Sorrell, The University of Sydney, AUSTRALIA
・Jane Knisley, NIAID, USA
Li Yang Hsu, Saw Swee Hock School of Public Health, National University of Singapore, SINGAPORE
Seamus O’Brien, Director of Research & Development, Global Antibiotic Research & Development Partnership (GARDP), SWITZERLAND

※ Please kindly note that we will close the registration after reaching 350 Attendees.

If you have difficulty accessing the link, please try using another device (smartphone, etc.)

Contact

amed_amr@event-info.jp